Ipsen SA ADR (IPSEY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Ipsen SA ADR, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Ipsen SA ADR (IPSEY) has returned 27.34% so far this year and 60.55% over the past 12 months. Looking at the last ten years, IPSEY has achieved an annualized return of 14.02%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Aug 6, 2010, IPSEY's average daily return is +0.07%, while the average monthly return is +1.35%. At this rate, your investment would double in approximately 4.3 years.

Historically, 51% of months were positive and 49% were negative. The best month was Apr 2020 with a return of +40.9%, while the worst month was Apr 2012 at -29.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, IPSEY closed higher 35% of trading days. The best single day was Mar 20, 2020 with a return of +19.7%, while the worst single day was Apr 10, 2012 at -25.8%.

Ipsen SA ADR has an annualized alpha of 16.11%, beta of 0.21, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since August 09, 2010.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (73.46%) than losses (58.69%) — typical of diversified or defensive assets.
• Beta of 0.21 may look defensive, but with R² of 0.01 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

IPSEY ranks 89 for risk / return — in the top 89% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Ipsen SA ADR (IPSEY) and compare them to a chosen benchmark (S&P 500 Index).

Ipsen SA ADR provided a 0.86% dividend yield over the last twelve months, with an annual payout of $0.40 per share. The company has been increasing its dividends for 5 consecutive years.

The table displays the monthly dividend distributions for Ipsen SA ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Ipsen SA ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ipsen SA ADR was 77.92%, occurring on Mar 19, 2020. Recovery took 1472 trading sessions.

The current Ipsen SA ADR drawdown is 3.16%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Ipsen SA ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Ipsen SA ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.